Role of topical intranasal steroids in pediatric hearing loss due to otitis media with effusion: the experiences

Swain, Santosh Kumar; Behera, Ishwar Chandra; Agrawala, Rohit; Shajahan, Nibi

doi:10.18203/issn.2454-5929.ijohns20195695

Cited by 3 publications

(2 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…16 They reduce the release of inflammatory mediators and cytokines, so reduce nasal mucosal inflammation. 17 These give symptomatic relief when used continuously or as required. However, these are the most effective when used regularly, as the onset of action is 7 to 12 hours, reaching maximum benefit within two weeks 18 Intranasal corticosteroids are highly effective in reducing nasal obstruction and congestion.…”

Section: Intranasal Corticosteroidmentioning

confidence: 99%

Current treatment options for allergic rhinitis: a review

Swain

Singh

2023

Int J Res Med Sci

View full text Add to dashboard Cite

Allergic rhinitis (AR) is an immunoglobulin E-mediated inflammatory reaction in the nasal mucosa caused by inhaled allergens such as dust, pollen, mold, or animal dander. AR is a common chronic disease that is often ignored, misdiagnosed, and/or mistreated. Clinically, AR is characterized by four major symptoms such as rhinorrhea, sneezing, nasal itching, and nasal congestion. It can be associated with certain co-morbid conditions like asthma and nasal polyposis. AR is diagnosed by taking proper history taking, nasal examination, and allergy tests. A proper understanding of the pathophysiology of AR can lead to improved treatment of this disorder. The treatment for AR should target symptoms to improve the quality of life for patients. Undertreatment of AR often impairs quality of life. The important concern in the treatment of AR is the patient’s adherence to the treatment. Novel treatments are needed for cheaper, early, better, and more permanent symptom resolution in AR. Evidence-based guidelines for AR treatment are helpful to improve disease control. The treatment of AR includes avoidance of relevant allergens, appropriate pharmacotherapy, immunotherapy, patient education, and follow-up. Intranasal corticosteroids are the most effective modality of treatment for AR. This review article discusses details of current treatment options for AR.

show abstract

Section: Intranasal Corticosteroidmentioning

confidence: 99%

Current treatment options for allergic rhinitis: a review

Swain

Singh

2023

Int J Res Med Sci

View full text Add to dashboard Cite

show abstract

“…It can present itself as speech, languageand sometimes as behavioral and educational problems. Due to the myringotomy and the placement of grommets, the hearing suddenly improves, and the child's active learning process is not disturbed and does not leave friends behind [8][9] . Secretory otitis media was diagnosed in 3.1% of first-grade students and 1.5% of second-grade students.…”

Section: Introductionmentioning

confidence: 99%

Efficacy of Grommet Insertion for Improvement in Hearing among Patients of Secretory Otitis Media

Zada¹,

Tahir²,

Habib³

et al. 2021

PJMHS

View full text Add to dashboard Cite

Aim: To determine the improvement of hearing after grommet insertion in patients with secretory otitis media. Study Design:A Quasi-Experimental study. Place and Duration: ENT, Head & Neck Surgery department of Lady Reading Hospital MTI, Peshawar and Azra Nahid Medical College, Lahore for duration of two years from February 2019 to February 2021. Methods: The study was performed on 48 ears with secretory otitis media. Before the operation,evaluation of both ears along with tympanmontometry and Pure Tone Audiometry were performed. Documentation ofhearing loss was done pre-operatively. During the operation accomplished under GA, a grommetwas placed in the anterior inferior quadrant of the tympanic membrane. After the surgery, PTA was repeated in the postoperative period before the patient was discharged from the hospital. Results:Our study included 28 patients with secretory otitis media and a total of 48 ears. Of the ears, 27 (56.25%) were male and 21 (43.75%) were female. Both ears were affected in 21 patients. Two patients had unilateral ear involvement. The right ear was affected in 26 cases (51.1%) and the left ear in 22 cases (48.9%). 7-55 years was the age range of the patients and 14.10 ± 9.11 years was the mean age. The degree of preoperative hearing loss was mild (20-40 dB) in 5 (10.41%) ears, moderate (40-60 dB) in 37 (77.1%) ears and severe (60-80 dB) in 6 (12.5%) ears. The degree of postoperative hearing loss was mild (20-40 dB) in 36 ears (75%), moderate (40-60 dB) in 11 ears (22.9%) and severe (60-80 dB) in one ear (2.1%). Hearing improvement was not seen in 8 (16.6%) ears, an improvement of 5-10 dB in 34 (70.8%) ears, and an improvement of 10-20 dB in 6 (12.5%) ears. There was a statistically significant difference between preoperative and postoperative hearing loss in the ears, the hearing loss was significantly less after grommet insertion; p = 0.017. Conclusion:The insertion of Grommet provides a significant improvement in hearing in patients with secretory otitis media. Keywords:Pure tone audiometry, Tympanometry, Middle ear, Secretory otitis Media and Grommets.

show abstract

A Review on Novel Therapeutic Modalities and Evidence-based Drug Treatments against Allergic Rhinitis

Kumar,

Deshmukh

2024

CPD

View full text Add to dashboard Cite

Allergic rhinitis (AR) is an IgE-mediated atopic disease that occurs due to inhaled antigens in the immediate phase. Misdiagnosis, insufficient treatment, or no treatment at all are frequent problems associated with the widespread condition known as chronic allergic rhinitis. AR symptoms include runny, itchy, stuffy, and sneezing noses. Asthma and nasal polyps, for example, sometimes occur simultaneously in patients. In order for people living with AR to be as comfortable and productive as possible, treatment should center on reducing their symptoms. The online sources and literature, such as Pubmed, ScienceDirect, and Medline, were reviewed to gather information regarding therapeutic modalities of AR and evidence-based treatments for the disease as the objectives of the present study. An increasing number of people are suffering from AR, resulting in a heavy financial and medical burden on healthcare systems around the world. Undertreating AR frequently results in a decline in quality of life. Treatment compliance is a critical challenge in the administration of AR. Innovative therapies are needed for RA to provide patients with symptom alleviation that is less expensive, more effective, and longer duration of action. Evidence-based guidelines are helpful for managing AR illness. Treating AR according to evidence-based standards can help in disease management. AR treatment includes allergen avoidance, drug therapy, immunotherapy, patient education, and follow-up. However, AR treatment with intranasal corticosteroids is more popular. Hence, in this review article, treatment options for AR are discussed in depth. We also discussed the incidence, causes, and new treatments for this clinical condition.

show abstract

Role of topical intranasal steroids in pediatric hearing loss due to otitis media with effusion: the experiences

Cited by 3 publications

References 16 publications

Current treatment options for allergic rhinitis: a review

Current treatment options for allergic rhinitis: a review

Efficacy of Grommet Insertion for Improvement in Hearing among Patients of Secretory Otitis Media

A Review on Novel Therapeutic Modalities and Evidence-based Drug Treatments against Allergic Rhinitis

Contact Info

Product

Resources

About